Elyse Stock - Net Worth and Insider Trading

Elyse Stock Net Worth

The estimated net worth of Elyse Stock is at least $135,928 dollars as of 2024-06-09. Elyse Stock is the Chief Medical Officer of Biohaven Pharmaceutical Holding Co Ltd and owns about 9,654 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $135,928. Details can be seen in Elyse Stock's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Elyse Stock has not made any transactions after 2021-12-15 and currently still holds the listed stock(s).

Transaction Summary of Elyse Stock

To

Elyse Stock Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Elyse Stock owns 1 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) .

Click here to see the complete history of Elyse Stock’s form 4 insider trades.

Insider Ownership Summary of Elyse Stock

Ticker Comapny Transaction Date Type of Owner
BHVN Biohaven Pharmaceutical Holding Co Ltd 2021-12-15 Chief Medical Officer

Elyse Stock Latest Holdings Summary

Elyse Stock currently owns a total of 1 stock. Elyse Stock owns 9,654 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of December 15, 2021, with a value of $135,928.

Latest Holdings of Elyse Stock

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BHVN Biohaven Pharmaceutical Holding Co Ltd 2021-12-15 9,654 14.08 135,928

Holding Weightings of Elyse Stock


Elyse Stock Form 4 Trading Tracker

According to the SEC Form 4 filings, Elyse Stock has made a total of 4 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the sale of 28,858 shares on December 15, 2021, which brought Elyse Stock around $3 Million.

Insider Trading History of Elyse Stock

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Elyse Stock Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Elyse Stock Ownership Network

Ownership Network List of Elyse Stock

No Data

Ownership Network Relation of Elyse Stock

Insider Network Chart

Elyse Stock Owned Company Details

What does Biohaven Pharmaceutical Holding Co Ltd do?

Who are the key executives at Biohaven Pharmaceutical Holding Co Ltd?

Elyse Stock is the Chief Medical Officer of Biohaven Pharmaceutical Holding Co Ltd. Other key executives at Biohaven Pharmaceutical Holding Co Ltd include VP & Chief Accounting Officer George C. Clark , Chief Financial Officer James Engelhart , and Officer Matthew Buten .

Biohaven Pharmaceutical Holding Co Ltd (BHVN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biohaven Pharmaceutical Holding Co Ltd Insider Transactions

No Available Data

Elyse Stock Mailing Address

Above is the net worth, insider trading, and ownership report for Elyse Stock. You might contact Elyse Stock via mailing address: 215 Church Street New Haven Ct 06510.

Discussions on Elyse Stock

No discussions yet.